Spark Investment Management’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Spark Investment Management’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-303,000	Closed	-$5.93M	–	879
2018 Q3	$5.93M	Sell	303,000 -161,200	-35%	-$3.06M	0.34%	85
2018 Q2	$7.69M	Buy	464,200 +394,500	+566%	+$6.02M	0.45%	52
2018 Q1	$989K	Buy	+69,700	New	+$1.03M	0.06%	333
2014 Q2	–	Sell	-126,600	Closed	-$1.91M	–	795
2014 Q1	$1.91M	Sell	126,600 -52,600	-29%	-$594K	0.3%	97
2013 Q4	$1.36M	Buy	+179,200	New	+$966K	0.24%	142

Other funds holding HZNP

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SCM

Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Spark Investment Management's HZNP Position: Q4 2018 in Review

Spark Investment Management sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2018, closing a stake of 303,000 shares — an estimated $5.93M sold.

Spark Investment Management first reported a position in HZNP in Q4 2013 and held it in 5 quarters. The position peaked at $7.69M in Q2 2018. 239 funds tracked by Wall St. Rank hold HZNP as of Q4 2018.

Spark Investment Management reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2018 after selling out during the quarter.
Spark Investment Management sold 303,000 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2018, an estimated $5.93M.
Spark Investment Management first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2013 and held it in 5 quarters.
Spark Investment Management's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $7.69M in Q2 2018.
239 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2018.

Based on Spark Investment Management's 13F filing for Q4 2018, filed 12 Feb 2019.